The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of...
ASTRO
This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy.
News | Image Guided Radiation Therapy (IGRT) | May 24, 2017
May 24, 2017 — The University Medical Centre (UMC) Utrecht in the Netherlands recently treated the first patient as...
News | Radiation Therapy | May 19, 2017
May 19, 2017 — Registration has opened for the 59th Annual Meeting of the American Society for Radiation Oncology (...
News | Treatment Planning | May 15, 2017
May 15, 2017 — RaySearch demonstrated a new Monte Carlo dose planning feature for...
News | Stereotactic Body Radiation Therapy (SBRT) | May 11, 2017
May 11, 2017 — Accuray Inc. announced that...
News | Radiation Therapy | February 17, 2017
February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...
Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.
I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland.
News | Radiation Therapy | February 06, 2017
February 6, 2017 — A study published in the February issue of...
Sponsored Content | Videos | Radiation Oncology | January 05, 2017
Join Chris Toth, president, Oncology Systems Americas, for a look at Varian’s new product introductions and major...
Sponsored Content | Videos | Quality Assurance (QA) | December 20, 2016
Learn more about myQA, IBA’s unique platform that connects QA applications, people, and know-how through a central...
Technology | Treatment Planning | December 20, 2016
December 20, 2016 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Siemens’ Somatom...
Sponsored Content | Videos | Radiation Therapy | November 18, 2016
Accuray recently unveiled the company’s newest innovation, the Radixact Treatment Delivery System, a uniquely smart...
News | Proton Therapy | October 28, 2016
October 27, 2016 — IBA announced in September that 50,000 patients have been treated by clinical partners using IBA’...
News | Prostate Cancer | October 27, 2016
October 27, 2016 — Augmenix Inc. announced the three-year results from the SpaceOAR System...
News | Treatment Planning | October 27, 2016
October 27, 2016 — University Medical Center Groningen (UMCG) in the Netherlands has selected RayStation as its...
News | Radiation Therapy | October 25, 2016
October 25, 2016 — Dicerna Pharmaceuticals Inc. announced in September that the company will focus its resources on...
News | Brachytherapy Systems | October 25, 2016
October 25, 2016 — For men with intermediate-risk...
News | Radiation Therapy | October 25, 2016
October 25, 2016 — Stereotactic body radiation therapy (SBRT) is a specialized and highly targeted method of...
News | Radiation Therapy | October 19, 2016
October 19, 2016 — IBA (Ion Beam Applications SA) and Philips announced in September the launch of a dedicated...
News | Radiation Therapy | October 19, 2016
October 19, 2016 — A Yale Cancer Center team completed a multi-institutional analysis of treatment options for...
News | Radiation Therapy | October 18, 2016
October 18, 2016 — The association between provider case volume and outcomes has long been suggested in cancer care...
